Global Active Pharmaceutical Ingredients Market Report 2020: Data from 2018, 2019, Estimates for 2020 and Projection of CAGR through 2025

News provided by

Jan 08, 2021, 10:15 ET

DUBLIN, Jan. 8, 2021 /PRNewswire/ -- The "Active Pharmaceutical Ingredients: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global market for active pharmaceutical ingredients (APIs) should grow from $135.4 billion in 2020 to $173.3 billion by 2025, at a compound annual growth rate (CAGR) of 5.1% for the period of 2020-2025.

This report is an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing trends and regulatory guidelines that impact the procurement of APIs are studied here. The increasing importance of outsourced API manufacturing activities and the impact on the pharmaceutical industry are covered in the report.

The global API market is expected to grow over the next five years, driven by the increasing demand for pharmaceutical products such as generics and biological drugs, price impacts from COVID-19 and the increasing demand for critical drugs, which are in short supply due to the pandemic.

In this report, the API market is segmented into molecular entity, manufacturer type, end use, and region. Further, it is segmented into two molecular entity groups: natural and synthetic API. Synthetic APIs are further segmented into chemical synthesis, biocatalytic and cell culture. Under the category of molecular entity, APIs are segmented into small molecules and large molecules. By sourcing type, the market is segmented into the captive market, merchant market and contract manufacturing organization (CMO). In terms of end use, the market is segmented into clinical trial use and commercial use.

In terms of geography, this report analyzes the market by the following regions: North America, Europe, Asia-Pacific, and Rest of the World (Latin America and the Middle East). The API market is very fragmented. Therefore, attempts have been made to present the market share held by selected companies.

The report includes:

Estimation of the market size and analyses of market trends, with data from 2018, 2019, estimates for 2020 and projection of CAGR through 2025
Highlights of quantitative and qualitative data of the API market by molecular entity, manufacturer type, origin, end use and region
Detailed description of API sources, production methods, route of synthesis, and contract manufacturing organizations
Information on regulatory perspective on production methods of API and discussion on harmonization of API GMP standards and supply chain integrity
Discussion on issues like patent expiry and its impact on the pharmaceutical market, and details of changes in pharmaceutical drug development
Coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
Company profiles of major players of the industry, including Actavis PLC, BASF AG, Cambrex Corp., GlaxoSmithKline PLC and Sun Pharmaceutical Industries Ltd

Key Topics Covered:

Chapter 1: Introduction

Chapter 2: Summary and Highlights

Chapter 3: Active Pharmaceutical Ingredients - Introduction

Pharmaceutical Industry Overview
Patent Expiry Impact on the Pharmaceutical Market
Changes in Pharmaceutical Drug Development
Drug Discovery and Development Process
Target Identification and Validation
Technologies for Drug Discovery
Pharmaceutical Business Model
Pharmaceutical Market Dynamics
The Cost of Drug Development
Global Pharmaceutical Supply Chain
API Defined
Sources of APIs
API Production Methods
API Production: Route of Synthesis
Production Methods
Active Pharmaceutical Ingredient Market
Market Dynamics
Impact of COVID on API Production and Supply Chain
API Pricing Trends and Increases Amidst COVID-19
Porter's Five-Force Analysis in the API Market
Threat of New Entrants
Threat of Substitute Products or Services
Bargaining Power of Customers (Buyers)
Bargaining Power of Suppliers
Intensity of Competitive Rivalry
Current State of Active Pharmaceutical Ingredient Regulations
Harmonization of API GMP Standards and Supply Chain Integrity
CMO/CDMO Regulations
Regulation in the U.S.
Regulation in Europe

Chapter 4: Active Pharmaceutical Ingredients Market by Manufacturer/ Service Provider

Introduction and Global Markets
The API Market by Manufacturer Type
Captive Market: Market Analysis
Merchant Market: Market Analysis
Contract Manufacturing Organizations (CMOs): Market Analysis

Chapter 5: Active Pharmaceutical Ingredients Market by End Use

Introduction and Global Markets
Clinical Trial: Market Analysis
Commercial: Market Analysis

Chapter 6: Active Pharmaceutical Ingredients by Origin

Introduction and Market Analysis
Natural Origin: Types and Market Analysis
Plant Sources
Animal Sources
Others
Market Size and Forecast
Synthetic APIs: Types and Market Analysis
Overview
Market Size and Forecast
Chemical Synthesis: Introduction and Market Analysis
Biocatalysis: Introduction and Market Analysis
Cell Culture Methods: Introduction and Market Analysis

Chapter 7: Active Pharmaceutical Ingredients Market by Molecule Type

Introduction and Global Markets
Small Molecules: Types and Market Analysis
Market Size and Forecast
Branded Small Molecule APIs
Generic APIs
Biologics: Types and Market Analysis
Top-Selling Biologics
Market Size and Forecast
Branded Biologic APIs
Biosimilar APIs

Chapter 8: Active Pharmaceutical Ingredients Market by Region

Chapter 9: Supplier Landscape and Key Industry Developments

Supplier Landscape
Captive Manufacturers
Merchant API Manufacturers
CMOs/CDMOs
API Fragmentation: -Reasons for Fragmented Industry Structure
Recent Industry and Investment Activities
Impact of COVID-19 on API Manufacturers

Chapter 10: Company Profiles

Abbvie Contract Manufacturing
Aesica Pharmaceuticals Ltd.
Aurobindo Pharma
Actavis Plc
Albany Molecular Research Inc. (Amri)
Avid Bioservices Inc.
BASF AG
Boehringer Ingelheim
Cambrex Corp.
CIPLA
CSPC Pharmaceutical Group
Corden Pharma International Gmbh
Dishman Group
Divis Laboratories Ltd.
Dr Reddy's Laboratory
Fareva Group
Glaxosmithkline Plc
Halo Pharma
Hetero
Johnson Matthey Pharmaceutical Materials Inc.
Jubilant Life Sciences Ltd.
Lonza
Lupin
Merck Kgaa
Mylan N.V.
Novartis AG
Patheon
Pfizer Centreone
Piramal Pharma Solutions
Shandong Xinhua Pharmaceutical Co. Ltd.
Siegfried Ag
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries, Inc.
Wuxi Apptec
Zhejiang Chemicals Import/Export Corp.
Zhuhai United Laboratories Co. Ltd.

Chapter 11: Appendix

For more information about this report visit https://www.researchandmarkets.com/r/dm1luq

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets